Elevance Health Total Liabilities 2010-2025 | ELV
Elevance Health total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Elevance Health total liabilities for the quarter ending March 31, 2025 were $77.097B, a 8.31% increase year-over-year.
- Elevance Health total liabilities for 2024 were $75.463B, a 8.54% increase from 2023.
- Elevance Health total liabilities for 2023 were $69.523B, a 4.66% increase from 2022.
- Elevance Health total liabilities for 2022 were $66.425B, a 8.3% increase from 2021.
| Elevance Health Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $75,463 |
| 2023 | $69,523 |
| 2022 | $66,425 |
| 2021 | $61,332 |
| 2020 | $53,416 |
| 2019 | $45,725 |
| 2018 | $43,030 |
| 2017 | $44,037 |
| 2016 | $39,983 |
| 2015 | $38,674 |
| 2014 | $37,425 |
| 2013 | $34,809 |
| 2012 | $35,153 |
| 2011 | $28,875 |
| 2010 | $26,354 |
| 2009 | $27,262 |
| Elevance Health Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $77,097 |
| 2024-12-31 | $75,463 |
| 2024-09-30 | $72,654 |
| 2024-06-30 | $70,691 |
| 2024-03-31 | $71,184 |
| 2023-12-31 | $69,523 |
| 2023-09-30 | $71,939 |
| 2023-06-30 | $70,856 |
| 2023-03-31 | $71,580 |
| 2022-12-31 | $66,425 |
| 2022-09-30 | $66,983 |
| 2022-06-30 | $65,010 |
| 2022-03-31 | $64,455 |
| 2021-12-31 | $61,332 |
| 2021-09-30 | $62,252 |
| 2021-06-30 | $61,051 |
| 2021-03-31 | $61,765 |
| 2020-12-31 | $53,416 |
| 2020-09-30 | $52,653 |
| 2020-06-30 | $53,521 |
| 2020-03-31 | $50,706 |
| 2019-12-31 | $45,725 |
| 2019-09-30 | $46,477 |
| 2019-06-30 | $45,058 |
| 2019-03-31 | $44,525 |
| 2018-12-31 | $43,030 |
| 2018-09-30 | $45,351 |
| 2018-06-30 | $45,642 |
| 2018-03-31 | $46,288 |
| 2017-12-31 | $44,037 |
| 2017-09-30 | $42,362 |
| 2017-06-30 | $41,806 |
| 2017-03-31 | $42,852 |
| 2016-12-31 | $39,983 |
| 2016-09-30 | $39,656 |
| 2016-06-30 | $39,829 |
| 2016-03-31 | $40,312 |
| 2015-12-31 | $38,674 |
| 2015-09-30 | $39,100 |
| 2015-06-30 | $41,201 |
| 2015-03-31 | $41,212 |
| 2014-12-31 | $37,425 |
| 2014-09-30 | $37,764 |
| 2014-06-30 | $37,927 |
| 2014-03-31 | $37,340 |
| 2013-12-31 | $34,809 |
| 2013-09-30 | $35,455 |
| 2013-06-30 | $35,080 |
| 2013-03-31 | $35,091 |
| 2012-12-31 | $35,153 |
| 2012-09-30 | $32,001 |
| 2012-06-30 | $30,891 |
| 2012-03-31 | $28,968 |
| 2011-12-31 | $28,875 |
| 2011-09-30 | $28,832 |
| 2011-06-30 | $26,696 |
| 2011-03-31 | $26,940 |
| 2010-12-31 | $26,354 |
| 2010-09-30 | $26,671 |
| 2010-06-30 | $26,370 |
| 2010-03-31 | $26,662 |
| 2009-12-31 | $27,262 |
| 2009-09-30 | $26,630 |
| 2009-06-30 | $27,091 |
| 2009-03-31 | $27,907 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $76.834B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.524B | 26.54 |
| CVS Health (CVS) | United States | $81.417B | 10.12 |
| Cencora (COR) | United States | $57.577B | 20.03 |
| DiDi Global (DIDIY) | China | $25.180B | 26.75 |
| Natera (NTRA) | United States | $21.599B | 0.00 |
| Labcorp Holdings (LH) | United States | $20.908B | 16.96 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.318B | 0.00 |
| CochLear (CHEOY) | Australia | $13.009B | 0.00 |
| Solventum (SOLV) | United States | $12.815B | 13.57 |
| ICON (ICLR) | Ireland | $12.075B | 11.23 |
| Revvity (RVTY) | United States | $11.607B | 19.97 |
| Viatris (VTRS) | United States | $10.727B | 3.69 |
| Medpace Holdings (MEDP) | United States | $9.208B | 24.45 |
| Avantor (AVTR) | United States | $9.009B | 13.09 |
| Sonic Healthcare (SKHHY) | Australia | $8.842B | 0.00 |
| HealthEquity (HQY) | United States | $8.418B | 36.87 |
| Charles River Laboratories (CRL) | United States | $7.762B | 15.21 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.052B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.840B | 28.50 |
| BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.880B | 37.45 |
| Alignment Healthcare (ALHC) | United States | $2.651B | 0.00 |
| Concentras Parent (CON) | United States | $2.593B | 14.98 |
| Organon (OGN) | United States | $2.550B | 2.71 |
| GeneDx Holdings (WGS) | United States | $2.351B | 90.54 |
| Ardent Health (ARDT) | United States | $2.073B | 8.84 |
| Progyny (PGNY) | United States | $2.012B | 44.28 |
| PACS (PACS) | United States | $1.966B | 0.00 |
| Premier (PINC) | United States | $1.750B | 13.28 |
| GoodRx Holdings (GDRX) | United States | $1.725B | 34.50 |
| Teladoc Health (TDOC) | United States | $1.451B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.316B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.131B | 8.60 |
| CareDx (CDNA) | United States | $1.115B | 17.41 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.931B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 7.41 |
| Nutex Health (NUTX) | United States | $0.645B | 9.76 |
| Embecta (EMBC) | United States | $0.606B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.582B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.487B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.473B | 10.65 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| So-Young (SY) | China | $0.430B | 0.00 |
| Enhabit (EHAB) | United States | $0.359B | 29.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.331B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.236B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Pheton Holdings (PTHL) | China | $0.142B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |